Abstract
A substrate-controlled stereoselective semi-reduction of alkynes with MeOH as the hydrogen source has been developed, and readily available Cu(OAc)2 (copper acetate) is utilized as an optimal catalyst. The detailed investigation of the mechanism revealed distinct catalytic processes for the (Z)- and (E)-alkenes, respectively. As a result, a diversity of alkynes (including terminal, internal alkynes etc.) were compatible under the mild reaction conditions. Furthermore, the high proportion of deuterium in Z-alkenes (up to 96%) was obtained using d4-methanol as a solvent.
Introduction
Alkenes as chemical feedstock have a wide range of applications in the field of materials science, medicinal chemistry, and pesticides.1 Ways to access the double bond include Wittig olefination, Julia olefination, Peterson olefination, cross-coupling, and olefin metathesis reaction.2 Beyond this, the semi-reduction of alkynes to alkenes is undoubtedly an attractive means.3 However, as one of the most primary procedures to produce alkenes, the semi-reduction of alkynes remains challenging. First, molecular hydrogen acts as the main hydrogen source in many transition-metal-based catalytic systems (such as Pd, Rh, Ir, Ru, Ni, Cu, etc.), but this source is flammable resulting in inconvenience and is potentially dangerous in large-scale industrial production. Secondly, absolute chemo- and stereoselectivity was hard to obtain under an H2 atmosphere for other unsaturated functional groups (alkene, nitrile, nitro, etc.). Hence, efforts for exploiting new and more efficient tactics are highly desirable.
Obviously, a catalytic transfer hydrogenation (CTH) strategy is preferable in the reduction of unsaturated hydrocarbons.4 Among the hydride donors, water and alcohols were safer and more eco-friendly than NH3BH3,5 BpinH,6 HCOOH,7 and polymethylhydrosiloxane (PHMS).8 For instance (Scheme 1), in 2018, Prabhu disclosed homogeneous palladium-catalyzed stereodivergent semi-reduction of alkynes to alkenes with water by employing ligand PCy3 and P(o-Tol)3.9 The next year, the Mei group also developed a palladium-catalyzed stereoselective semi-reduction of alkynes by regulation of the solvent.10 Yang and co-workers reported ligand-controlled iridium-catalyzed stereoselective semi-reduction of alkynes using ethanol as the hydrogen donor.11 These are all distinguished methods for the stereoselective semi-reduction of alkynes. To the best of our knowledge, non-noble metal-catalyzed methods for stereodivergent semi-reduction of alkynes using a CTH strategy are still insufficient, although a few copper-catalyzed semi-reduction of alkynes are known with equivalent amounts of base and limited substrate scope.12 With our interest in the catalytic systems of transition-metal and diboron compounds,13 we herein developed the Cu(OAc)2-catalyzed semi-reduction of alkynes under the aegis of B2pin2, and the absolute stereoselectivity of the products depended on the nature of substrates.
Scheme 1. Stereodivergent Catalytic Transfer Hydrogenation (CTH) of Alkynes.
Results and Discussion
We initiated the investigation using 1a as a template substrate, and semi-reduction product (Z)-2a was first detected with 68% yield in the presence of 10 mol % of Cu(OAc)2, 1.0 equiv of B2pin2 and 1.0 equiv of tBuOK in MeOH at 60 °C (Table 1, entry 1). Fortunately, the over-reduction product and (E)-2a were not detected in the mixture. Next, the screening of the copper catalysts revealed that Cu(II) species gave promising results while the reaction did not work with Cu powder. When Pd(OAc)2 was used as the catalyst, substrate 1a was recovered in quantitative yield.8 Cu(OAc)2·2H2O was selected as the candidate for slightly increasing the yield (Table 1, entries 2–8). We investigated the effect of various nitrogen-containing ligands on the influence of this transformation. When strong coordinate ligand 2,2′-bpy, 1,10-phen, and tpy were utilized, the yield of (Z)-2a decreased significantly and the reaction was almost inhibited (Table 1, entries 9–11). To our delight, when 4,4′-bpy was used as the partner of the transition-metal catalyst, the yield of (Z)-2a was up to 92% (Table 1, entry 12). The weaker coordination ability of 4,4′-bpy played the role of a monodentate ligand, rather than bidentate ligands for Cu(OAc)2.14 The function of the base is activation of the diborane compound, we attempted to lower the equivalents of tBuOK. A comparison with the above conditions showed that 0.3 equivalent of tBuOK exhibited a tiny decrease of (Z)-2a (Table 1, entries 13–14). Next, we screened ethanol or water as the solvent, the results of the reactions were not satisfactory (Table 1, entries 15–16). In summary, the optimized reaction conditions were identified as 10 mol % Cu(OAc)2·2H2O, 10 mol % 4,4′-bpy, 0.3 equiv of tBuOK, and 1.0 equiv of B2pin2 in methanol at 60 °C.
Table 1. Optimization of the Reaction Conditionsa.
entry | Cu catalyst | ligand | x | yield (%)b |
---|---|---|---|---|
1 | Cu(OAc)2 | none | 1.0 | 68 |
2 | Cu(OAc)2·2H2O | none | 1.0 | 69 |
3 | Cu(OTf)2 | none | 1.0 | 55 |
4 | CuCl | none | 1.0 | 10 |
5 | CuTc | none | 1.0 | 16 |
6 | Cu powder | none | 1.0 | <5 |
7 | Cu(CH3CN)4BF4 | none | 1.0 | 10 |
8 | Pd(OAc)2 | none | 1.0 | <5 |
9 | Cu(OAc)2·2H2O | 2,2′-bpy | 1.0 | 18 |
10 | Cu(OAc)2·2H2O | 1,10-phen | 1.0 | <5 |
11 | Cu(OAc)2·2H2O | tpy | 1.0 | <5 |
12 | Cu(OAc)2·2H2O | 4,4′-bpy | 1.0 | 92 |
13 | Cu(OAc)2·2H2O | 4,4′-bpy | 0.1 | 45 |
14 | Cu(OAc)2·2H2O | 4,4′-bpy | 0.3 | 90 |
15c | Cu(OAc)2·2H2O | 4,4′-bpy | 0.3 | 23 |
16d | Cu(OAc)2·2H2O | 4,4′-bpy | 0.3 | 0 |
Conditions: substrate 1a (0.3 mmol), Cu catalyst (10 mol %), ligand (10 mol %), B2pin2 (1.0 equiv), MeOH (2.0 mL) under a N2 atmosphere at 60 °C for 18 h.
Yields determined by 1H NMR with CH2Br2 as internal standard.
EtOH instead of MeOH.
H2O instead of MeOH.
With the optimal reaction conditions established above, we investigated a variety of substituted N-protected arylpropargyl amine derivatives (Table 2). The substrates with substitutions in para and meta-positions including electron-donating and electron-withdrawing groups were well transformed and afforded the corresponding semi-reduction products in good to excellent yields (2a–c). It is worth noting that ortho-substitution of the benzene ring had little impact on the yield of (Z)-alkene (2d). In addition, the alkynes installed with a heteroaromatic ring such as pyridyl and thienyl were also compatible under the reaction conditions and delivered the target products (2e, 2f) in good yields. Next, when the Boc protecting group of the nitrogen atom was replaced with phthalate or benzoxazolinone, that could convert into the desired products in satisfactory yields (2g–k). Especially, the nitrile and benzyl ether (BnO) functional group could be stable under the reductive conditions (2i, 2l). It was noteworthy that 2m was obtained with electron deficient 3-phenylpropiolonitrile as the substrate. Diaryl alkyne and diaryl diyne were also suitable substrates under the current conditions (2n, 2o). Furthermore, internal alkyl alkyne also produced (Z)-alkene in moderate yield with excellent stereoselectivity (2p). Meanwhile, we examined terminal alkynes, including phenylacetylene derivatives (2q, 2r), propargyl amine derivatives (2s–v), and long-chain terminal alkyne (2w), that could be smoothly converted to the corresponding terminal alkenes.
Table 2. Synthesis of (Z)-Alkenesa.
Conditions: substrate 1 (0.3 mmol), Cu(OAc)2·2H2O (10 mol %), 4,4′-bpy (10 mol %), B2pin2 (1.0 equiv), MeOH (2.0 mL) under a N2 atmosphere at 60 °C for 18 h; Isolated yields; Unless otherwise noted, products Z/E > 20:1.
On the other hand, internal alkynes with a carboxylate or an amide group (Table 3), provided the (E)-geometric products (2x–z) rather than (Z)-isomers.
Table 3. Synthesis of (E)-Alkenesa.
Conditions: substrate 1 (0.3 mmol), Cu(OAc)2·2H2O (10 mol %), 4,4′-bpy (10 mol %), B2pin2 (1.0 equiv), MeOH (2.0 mL) under a N2 atmosphere at 60 °C for 18 h; Isolated yields. Unless otherwise noted, products E/Z > 20:1.
Additionally, when d4-methanol was used as the solvent in the transformation (Figure 1), highly deuterated (up to 96%) alkenes were obtained (d-2g, d-2k). As we observed by 1H NMR of d-2s, the cis-terminal hydrogen was deuterated with 50% incorporation. Naturally, we postulated that the hydrogen atom of the terminal alkynes underwent hydrogen–deuterium exchange before the semi-reduction reaction, which was verified by the control experiments (see the Supporting Information (SI) for details).
Figure 1.
Synthesis of deuterated (Z)-alkenes. Conditions: substrate 1 (0.3 mmol), anhydrous Cu(OAc)2 (10 mol %), 4,4′-bpy (10 mol %), B2pin2 (1.0 equiv), CD3OD (2.0 mL) under a N2 atmosphere at 60 °C for 18 h; Isolated yields. Unless otherwise noted, products Z/E > 20:1. The deuterium content was determined by 1H NMR.
To gain a deep understanding of this process, more control experiments were conducted (Scheme 2). We synthesized the possible reaction intermediate vinyl boronate 3 that was employed under the standard conditions with various equivalents of B2pin2. One surprising result was that if the amount of B2pin2 used is 1 or more equivalents, the yield of 2n was <5%. However, the use of less than one equivalent gave a high yield of 2n (Scheme 2). This may be attributed to the transmetalation process of the vinyl copper intermediate with B2pin2 (see the Supporting Information (SI) for details).15
Scheme 2. Effect of Various Equivalents of B2pin2 for the Transformation of Possible Intermediates.
Next, in a control experiment (Scheme 3), compound 4 containing both an alkyne bond group and an allyl group could be converted into (Z)-5 with retention of the allyl group under the standard conditions (Scheme 3, 1). However, compound 5 would undergo deallylation under the standard conditions, which suggests the existence of a Cu-hydride species in the process (Scheme 3, 2).16 Next, to ascertain if β-hydride elimination of a Cu(II)-alkyl intermediate may be involved in the process, isomerization experiments were performed, which were all negative (Scheme 3, 3–4).3b
Scheme 3. Control Experiments.
Based on the results of control experiments as well as the literature precedents,17 we speculate the proposed mechanism, as shown in Scheme 4. Initially, the copper–boryl complex (Bpin-CuL) was generated from 4,4′-bpy (L), B2pin2, and Cu(OAc)2 with the aid of tBuOK. Then Bpin-CuL was added to the carbon–carbon triple bond of 1, which produced the vinyl copper intermediate (path 1).18 Finally, the protonolysis of the vinyl C–Cu bond provided vinyl boronates, which could be transformed into the target product (Z)-2 under the Cu-catalyzed protodeboronation and protonation. In path 2, the intermediate Bpin-CuL might facilitate the hydrogen atom transfer from MeOH to copper, affording a copper hydride species. Then, [CuH] was added to the alkyne to deliver the vinyl copper intermediate, and (Z)-2 was formed from the protonolysis of the vinyl C–Cu bond.
Scheme 4. Proposed Mechanism.
On the other hand, Bpin-CuL could coordinate with one of the oxygen atoms of 1x, and then the conjugate addition of Bpin to the alkynoate would produce the allenolate intermediate. The Cu–O cleavage associated with enol-isomerism affords acrylate (E)-Bpin-2x and Cu(OMe)L. Finally, (E)-2x was formed by C–B bond cleavage of (E)-Bpin-2x as described in path 1. The Cu(OMe)L returned to the catalytic cycle and was transformed into the active species Bpin-CuL.19
Conclusions
In conclusion, we discussed the interesting substrate-controlled copper-catalyzed stereoselective semi-reduction reactions of alkynes. Importantly, the high functionalized alkynes were compatible and the solvent also played the role of a hydrogen source in the process with the aid of B2pin2. On the basis of the comprehensive mechanism investigated, two rational catalytic cycles were proposed for different kinds of alkyne substrates. Efforts toward the reduction of other unsaturated bonds with the CTH strategy are currently underway in our lab.
Experimental Section
General Methods
1H and 13C NMR spectra were recorded on a Bruker DRX-400 spectrometer using CDCl3 as the solvent and TMS as an internal standard. The chemical shifts are referenced to signals at 7.26 and 77.0 ppm, respectively. The HRMS data were obtained on a high-resolution mass spectrometer (LCMS-IT-TOF). IR spectra were obtained either as potassium bromide plates or as liquid films between two potassium bromide pellets with a Bruker TENSOR 27 spectrometer. Melting points were determined with a Büchi Melting Point B-545 instrument. Unless otherwise stated, all reagents and solvents were purchased from commercial suppliers and used without further purification.
Representative Procedure for the Synthesis of Internal Alkynes 1
In a 25 mL round-bottom flask, aryl iodide (1 mmol), terminal alkyne (1.05 mmol), K2CO3 (2.0 mmol), Pd(PPh3)4 (0.1 mmol), and dimethylformamide (DMF) (10 mL) were successively added. The mixture was stirred at 60 °C for 24 h under a N2 atmosphere. Then the reaction was diluted with EtOAc (100 mL) and washed with aqueous NH4Cl (2 × 30 mL). The ethyl acetate layer was washed with brine (30 mL) and dried over anhydrous Na2SO4. The solvent was removed under vacuum. The crude product was purified by flash column chromatography (eluted with petroleum ether/ethyl acetate = 5/1–3/1) on silica gel to afford internal alkyne product 1. The characterization data of 1a,201b,211d,201e,221h,231i,24 and 1l(25) were consistent with the reported literature.
Representative Procedure for Synthesis of Alkenes 2
To a 20 mL sealed tube with a magnetic stirrer bar, Cu(OAc)2·2H2O (0.03 mmol), 4,4′-bpy (0.03 mmol), B2pin2 (0.30 mmol), tBuOK (0.09 mmol), alkyne 1 (0.30 mmol), and MeOH (2 mL) were successively added and vigorously stirred together at 60 °C under a N2 atmosphere. After the reaction completed, the mixture was cooled to room temperature. The reaction was quenched with saturated aq NH4Cl and extracted with EtOAc (3 × 15 mL). The combined ethyl acetate layer was washed with brine (10 mL) and dried over anhydrous Na2SO4. The solvent was removed under vacuum. The crude product was purified by flash column chromatography (eluted with petroleum ether/ethyl acetate) on silica gel to afford product 2.
Synthesis of (Z)-N-Allyl-4-methyl-N-(3-(p-tolyl)allyl)benzenesulfonamide (5)
To a 20 mL sealed tube with a magnetic stirrer bar, Cu(OAc)2·2H2O (0.03 mmol), 4,4′-bpy (0.03 mmol), B2pin2 (0.30 mmol), tBuOK (0.09 mmol), 4 (0.30 mmol), and MeOH (2 mL) were successively added and vigorously stirred together at 60 °C under a N2 atmosphere for 18 h. After the reaction completed, the mixture was cooled to room temperature. The reaction was quenched with saturated aq NH4Cl and extracted with EtOAc (3 × 15 mL). The combined ethyl acetate layer was washed with brine (10 mL) and dried over anhydrous Na2SO4. The solvent was removed under vacuum. The crude product was purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 5:1) on silica gel to afford product 5 (74 mg, 72%) as a light yellow oil. 1H NMR (400 MHz, chloroform-d) δ 7.71 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 7.9 Hz, 2H), 7.06 (d, J = 7.7 Hz, 2H), 6.53 (d, J = 11.7 Hz, 1H), 5.58 (ddt, J = 16.7, 10.0, 6.4 Hz, 1H), 5.47 (dt, J = 11.2, 6.4 Hz, 1H), 5.04–4.86 (m, 2H), 4.12 (dd, J = 6.5, 1.8 Hz, 2H), 3.77 (d, J = 6.4 Hz, 2H), 2.45 (s, 3H), 2.36 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 143.20, 137.34, 137.03, 133.30, 132.46, 132.32, 129.67, 128.95, 128.65, 127.23, 126.40, 118.99, 49.82, 44.65, 21.53, 21.19. High-resolution mass spectrometry-electrospray ionization (HRMS-ESI) (m/z): calcd for C20H23NO2SNa, [M + Na]+: 364.1347, found, 364.1354.
Synthesis of (Z)-4-Methyl-N-(3-(p-tolyl)allyl)benzenesulfonamide (6)26
To a 20 mL sealed tube with a magnetic stirrer bar, Cu(OAc)2·2H2O (0.02 mmol), 4,4′-bpy (0.02 mmol), B2pin2 (0.21 mmol), tBuOK (0.06 mmol), 5 (0.21 mmol), and MeOH (1.5 mL) were successively added and vigorously stirred together at 60 °C under a N2 atmosphere for 18 h. After the reaction completed, the mixture was cooled to room temperature. The reaction was quenched with saturated aq NH4Cl and extracted with EtOAc (3 × 15 mL). The combined ethyl acetate layer was washed with brine (10 mL) and dried over anhydrous Na2SO4. The solvent was removed under vacuum. The crude product was purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 3:1) on silica gel to afford product 6 (29 mg, 45%) as a light yellow oil. 1H NMR (400 MHz, chloroform-d) δ 7.78–7.73 (m, 2H), 7.36–7.26 (m, 3H), 7.11 (d, J = 7.7 Hz, 2H), 7.01 (d, J = 7.7 Hz, 2H), 6.50 (d, J = 11.5 Hz, 1H), 5.52 (dt, J = 10.9, 6.7 Hz, 1H), 4.73–4.53 (m, 1H), 3.87 (t, J = 6.4 Hz, 2H), 2.45 (s, 3H), 2.35 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 143.48, 137.32, 136.87, 132.94, 132.59, 129.73, 129.05, 128.53, 127.20, 125.67, 41.39, 21.55, 21.20.
Analytical Characterization Data of Substrates and Products
tert-Butyl (3-(3-Methoxyphenyl)prop-2-yn-1-yl)carbamate (1c)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 2:1) as a brown oil (196 mg, 74%). 1H NMR (400 MHz, chloroform-d) δ 7.21 (t, J = 8.0 Hz, 1H), 7.02 (d, J = 7.6 Hz, 1H), 6.96 (t, J = 1.9 Hz, 1H), 6.88 (dd, J = 8.4, 2.6 Hz, 1H), 4.87 (s, 1H), 4.16 (d, J = 5.3 Hz, 2H), 3.80 (s, 3H), 1.48 (s, 10H). 13C NMR (101 MHz, chloroform-d) δ 159.25, 155.32, 129.34, 124.20, 123.69, 116.54, 114.93, 85.23, 83.00, 80.00, 55.24, 31.20, 28.37. HRMS-ESI (m/z): calcd for C15H19NO3Na, [M + Na]+: 284.1263, found, 284.1260.
tert-Butyl (3-(Thiophen-3-yl)prop-2-yn-1-yl)carbamate (1f)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 4:1) as a brown solid (193 mg, 80%), mp = 94–96 °C. 1H NMR (400 MHz, chloroform-d) δ 7.43 (d, J = 3.1 Hz, 1H), 7.32–7.22 (m, 1H), 7.09 (d, J = 4.8 Hz, 1H), 4.85 (s, 1H), 4.26–4.01 (m, 2H), 1.47 (d, J = 2.8 Hz, 9H). 13C NMR (101 MHz, chloroform-d) δ 155.31, 129.85, 128.89, 125.28, 121.72, 85.03, 79.98, 78.26, 77.26, 31.19, 28.38. HRMS-ESI (m/z): calcd for C12H15NO2SNa, [M + Na]+: 260.0721, found, 260.0722.
2-(3-(p-Tolyl)prop-2-yn-1-yl)isoindoline-1,3-dione (1g)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 3:1) as a yellow solid (262 mg, 94%), mp = 165–167 °C. 1H NMR (400 MHz, chloroform-d) δ 7.91 (dq, J = 5.5, 2.8 Hz, 2H), 7.77 (dt, J = 6.1, 3.1 Hz, 2H), 7.32 (dd, J = 8.1, 2.0 Hz, 2H), 7.09 (d, J = 7.7 Hz, 2H), 4.69 (d, J = 2.1 Hz, 2H), 2.33 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 167.19, 138.63, 134.14, 132.12, 131.82, 128.95, 123.54, 119.22, 83.10, 81.90, 27.93, 21.47. HRMS-ESI (m/z): calcd for C18H14NO2, [M + H]+: 276.1025, found, 276.1031.
2-(3-(1,3-Dioxoisoindolin-2-yl)prop-1-yn-1-yl)phenyl Acetate (1j)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 3:1) as a light brown solid (180 mg, 56%), mp = 136–138 °C. 1H NMR (400 MHz, chloroform-d) δ 7.91 (dd, J = 5.5, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.0 Hz, 2H), 7.49 (dd, J = 7.7, 1.7 Hz, 1H), 7.35 (td, J = 7.8, 1.7 Hz, 1H), 7.19 (td, J = 7.7, 1.2 Hz, 1H), 7.07 (dd, J = 8.2, 1.1 Hz, 1H), 4.70 (s, 2H), 2.37 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 169.09, 167.02, 152.03, 134.23, 133.39, 132.06, 129.85, 125.81, 123.55, 122.26, 116.43, 87.50, 77.95, 27.83, 20.77. HRMS-ESI (m/z): calcd for C19H14NO4, [M + H]+: 320.0923, found, 320.0925.
3-(3-(p-Tolyl)prop-2-yn-1-yl)benzo[d]oxazol-2(3H)-one (1k)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 2:1) as a light brown solid (243 mg, 91%), mp = 77–79 °C. 1H NMR (400 MHz, chloroform-d) δ 7.32 (d, J = 7.8 Hz, 2H), 7.30–7.27 (m, 1H), 7.27–7.21 (m, 2H), 7.21–7.15 (m, 1H), 7.13 (d, J = 7.8 Hz, 2H), 4.87 (s, 2H), 2.36 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 153.81, 142.67, 139.14, 131.72, 130.30, 129.12, 123.99, 122.80, 118.71, 110.09, 109.32, 85.66, 80.07, 32.79, 21.51. HRMS-ESI (m/z): calcd for C17H14NO2, [M + H]+: 264.1025, found, 264.1028.
tert-Butyl (Z)-(3-(p-Tolyl)allyl)carbamate (2a)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 4:1) as a white solid (66 mg, 90%), mp = 65–66 °C. 1H NMR (400 MHz, chloroform-d) δ 7.22–7.07 (m, 4H), 6.52 (dt, J = 11.5, 1.9 Hz, 1H), 5.64 (dt, J = 11.6, 6.6 Hz, 1H), 4.70 (s, 1H), 4.05 (d, J = 6.6 Hz, 2H), 2.37 (s, 3H), 1.47 (s, 9H). 13C NMR (101 MHz, chloroform-d) δ 155.84, 136.97, 133.56, 130.98, 129.00, 128.71, 128.15, 79.41, 39.06, 28.42, 21.19. HRMS-ESI (m/z): calcd for C15H21NO2, [M + Na]+: 270.1470, found, 270.1475.
tert-Butyl (Z)-(3-(4-Fluorophenyl)allyl)carbamate (2b)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 4:1) as a white solid (70 mg, 92%), mp = 82–84 °C. 1H NMR (400 MHz, chloroform-d) δ 7.20 (dd, J = 8.3, 5.4 Hz, 2H), 7.04 (t, J = 8.7 Hz, 2H), 6.51 (d, J = 11.6 Hz, 1H), 5.67 (dt, J = 12.4, 6.5 Hz, 1H), 4.66 (s, 1H), 4.02 (s, 2H), 1.46 (d, J = 1.2 Hz, 9H). 13C NMR (101 MHz, chloroform-d) δ 161.86 (d, J = 246.9 Hz), 155.77, 132.45 (d, J = 3.3 Hz), 130.37 (d, J = 8.0 Hz), 129.96, 128.82, 115.23 (d, J = 21.4 Hz), 79.55, 38.91, 28.39. HRMS-ESI (m/z): calcd for C14H19NO2F, [M + H]+: 252.1400, found, 252.1399.
tert-Butyl (Z)-(3-(3-Methoxyphenyl)allyl)carbamate (2c)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 2:1) as a light yellow oil (65 mg, 83%). 1H NMR (400 MHz, chloroform-d) δ 7.34–7.26 (m, 1H), 6.87–6.71 (m, 3H), 6.53 (d, J = 11.6 Hz, 1H), 5.69 (dt, J = 11.1, 6.6 Hz, 1H), 4.68 (s, 1H), 4.05 (d, J = 6.6 Hz, 2H), 3.82 (s, 3H), 1.47 (s, 9H). 13C NMR (101 MHz, chloroform-d) δ 159.48, 155.79, 137.78, 131.00, 129.28, 129.20, 121.25, 114.28, 112.79, 77.25, 55.21, 39.02, 28.40. HRMS-ESI (m/z): calcd for C15H21NO3Na, [M + Na]+: 286.1419, found, 286.1428.
tert-Butyl (Z)-(3-(o-Tolyl)allyl)carbamate (2d)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 5:1) as a light yellow oil (50 mg, 68%). 1H NMR (400 MHz, chloroform-d) δ 7.30–7.15 (m, 4H), 7.11 (d, J = 6.3 Hz, 1H), 6.61 (d, J = 11.4 Hz, 1H), 5.76 (dt, J = 11.2, 6.7 Hz, 1H), 4.56 (s, 1H), 3.88 (d, J = 6.7 Hz, 2H), 2.28 (s, 3H), 1.46 (s, 9H). 13C NMR (101 MHz, chloroform-d) δ 155.77, 136.22, 135.46, 130.44, 129.92, 128.94, 128.64, 127.45, 125.52, 38.77, 28.41, 19.86. HRMS-ESI (m/z): calcd for C15H21NO2Na, [M + Na]+: 270.1470, found, 270.1478.
tert-Butyl (Z)-(3-(Pyridin-3-yl)allyl)carbamate (2e)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 2:1) as a light yellow oil (66 mg, 84%). 1H NMR (400 MHz, chloroform-d) δ 8.50 (d, J = 2.5 Hz, 2H), 7.57 (d, J = 7.9 Hz, 1H), 7.32–7.28 (m, 1H), 6.51 (d, J = 11.8 Hz, 1H), 5.83 (dt, J = 11.2, 6.6 Hz, 1H), 4.73 (s, 1H), 4.01 (d, J = 6.6 Hz, 2H), 1.46 (d, J = 1.1 Hz, 9H). 13C NMR (101 MHz, chloroform-d) δ 155.73, 149.78, 148.19, 135.73, 132.11, 131.55, 127.36, 123.18, 79.67, 38.93, 28.38. HRMS-ESI (m/z): calcd for C13H18N2O2Na, [M + Na]+: 257.1266, found, 257.1267.
tert-Butyl (Z)-(3-(Thiophen-3-yl)allyl)carbamate (2f)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 4:1) as a brown oil (67 mg, 94%). 1H NMR (400 MHz, chloroform-d) δ 7.34–7.28 (m, 1H), 7.22–7.11 (m, 1H), 7.07 (d, J = 5.0 Hz, 1H), 6.48 (d, J = 11.4 Hz, 1H), 5.62 (dt, J = 11.2, 6.5 Hz, 1H), 4.70 (s, 1H), 4.07 (d, J = 6.5 Hz, 2H), 1.47 (s, 9H). 13C NMR (101 MHz, chloroform-d) δ 155.84, 137.59, 128.39, 127.95, 125.46, 125.00, 123.71, 79.50, 77.25, 28.42. HRMS-ESI (m/z): calcd for C12H17NO2NaS, [M + Na]+: 262.0878, found, 262.0883.
(Z)-2-(3-(p-Tolyl)allyl)isoindoline-1,3-dione (2g)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 3:1) as a white solid (75 mg, 91%), mp = 86–88 °C. 1H NMR (400 MHz, chloroform-d) δ 7.91–7.81 (m, 2H), 7.73 (dd, J = 5.6, 3.0 Hz, 2H), 7.30 (d, J = 7.9 Hz, 2H), 7.21 (d, J = 7.8 Hz, 2H), 6.60 (d, J = 11.6 Hz, 1H), 5.63 (dt, J = 12.1, 6.4 Hz, 1H), 4.62 (dd, J = 6.5, 1.9 Hz, 2H), 2.38 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 168.01, 137.09, 133.94, 132.17, 131.88, 129.10, 128.74, 126.44, 125.17, 123.26, 36.59, 21.24. HRMS-ESI (m/z): calcd for C18H16NO2, [M + H]+: 278.1181; found, 278.1181.
(Z)-2-(3-(4-Methoxyphenyl)allyl)isoindoline-1,3-dione (2h)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 2:1) as a white solid (77 mg, 88%), mp = 109–111 °C. 1H NMR (400 MHz, chloroform-d) δ 7.87 (dd, J = 5.5, 3.1 Hz, 2H), 7.73 (dd, J = 5.5, 3.1 Hz, 2H), 7.35 (d, J = 8.6 Hz, 2H), 7.00–6.86 (m, 2H), 6.64–6.50 (m, 1H), 5.59 (dt, J = 11.3, 6.4 Hz, 1H), 4.61 (dd, J = 6.4, 1.9 Hz, 2H), 3.85 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 168.05, 158.81, 133.95, 132.17, 131.46, 130.12, 128.86, 124.32, 123.26, 113.84, 55.28, 36.60. HRMS-ESI (m/z): calcd for C18H16NO3, [M + H]+: 294.1130, found, 294.1139.
(Z)-4-(3-(1,3-Dioxoisoindolin-2-yl)prop-1-en-1-yl)benzonitrile (2i)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 2:1) as a white solid (79 mg, 92%), mp = 145–147 °C. 1H NMR (400 MHz, chloroform-d) δ 7.82 (dq, J = 6.7, 4.1, 3.3 Hz, 2H), 7.72 (dt, J = 5.2, 2.2 Hz, 2H), 7.65 (dd, J = 8.3, 1.9 Hz, 2H), 7.50 (d, J = 7.9 Hz, 2H), 6.61 (dd, J = 11.8, 2.0 Hz, 1H), 5.80 (dt, J = 11.3, 6.6 Hz, 1H), 4.51 (dd, J = 6.7, 2.0 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 167.86, 140.83, 134.17, 132.23, 131.98, 130.47, 129.42, 128.58, 123.36, 118.79, 110.94, 36.19. HRMS-ESI (m/z): calcd for C18H13N2O2, [M + H]+: 289.0977, found, 289.0984.
(Z)-2-(3-(1,3-Dioxoisoindolin-2-yl)prop-1-en-1-yl)phenyl Acetate (2j)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 3:1) as a white solid (72 mg, 75%), mp = 98–100 °C. 1H NMR (400 MHz, chloroform-d) δ 7.90–7.82 (m, 2H), 7.73 (qt, J = 4.8, 2.4 Hz, 2H), 7.57 (dd, J = 7.2, 2.0 Hz, 1H), 7.39–7.29 (m, 2H), 7.11 (dt, J = 7.7, 1.1 Hz, 1H), 6.51 (d, J = 11.3 Hz, 1H), 5.78 (dt, J = 11.2, 6.5 Hz, 1H), 4.44 (dt, J = 6.6, 1.3 Hz, 2H), 2.32 (d, J = 0.9 Hz, 3H). 13C NMR (101 MHz, chloroform-d) δ 169.10, 167.93, 148.46, 133.97, 132.14, 130.26, 129.15, 128.81, 127.77, 126.96, 126.08, 123.26, 122.32, 36.39, 20.93. HRMS-ESI (m/z): calcd for C19H16NO4, [M + H]+: 322.1079, found, 322.1089.
(Z)-3-(3-(p-Tolyl)allyl)benzo[d]oxazol-2(3H)-one (2k)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 3:1) as a white solid (74 mg, 93%), mp = 91–93 °C. 1H NMR (400 MHz, chloroform-d) δ 7.32–7.16 (m, 5H), 7.10 (dq, J = 5.8, 3.4 Hz, 2H), 6.84–6.67 (m, 2H), 5.68 (dt, J = 12.1, 6.4 Hz, 1H), 4.77 (dd, J = 6.4, 1.8 Hz, 2H), 2.42 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 154.32, 142.66, 137.71, 133.48, 132.90, 130.77, 129.31, 128.76, 124.17, 123.75, 122.45, 109.93, 108.87, 40.49, 21.27. HRMS-ESI (m/z): calcd for C17H16NO2, [M + H]+: 266.1181, found, 266.1189.
(Z)-(3-(Benzyloxy)prop-1-en-1-yl)benzene (2l)27
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 6:1) as a light yellow oil (52 mg, 77%). 1H NMR (400 MHz, chloroform-d) δ 7.46–7.26 (m, 10H), 6.68 (d, J = 11.9 Hz, 1H), 5.97 (dt, J = 12.2, 6.4 Hz, 1H), 4.58 (d, J = 3.2 Hz, 2H), 4.36 (dd, J = 6.3, 1.8 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 138.19, 136.67, 131.82, 128.97, 128.81, 128.42, 128.25, 127.91, 127.82, 127.20, 72.52, 66.97.
(Z)-3-Phenylacrylonitrile (2m)10
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 8:1) as a light yellow oil (25 mg, 65%). 1H NMR (400 MHz, chloroform-d) δ 7.88–7.74 (m, 2H), 7.45 (p, J = 4.0, 3.4 Hz, 3H), 7.13 (d, J = 12.1 Hz, 1H), 5.45 (d, J = 12.1 Hz, 1H). 13C NMR (101 MHz, chloroform-d) δ 148.73, 133.58, 130.99, 129.02, 128.94, 117.36, 95.08.
(Z)-1,2-Diphenylethene (2n)10
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 20:1) as a light yellow oil (41 mg, 76%). 1H NMR (400 MHz, chloroform-d) δ 7.30 (dtt, J = 16.4, 6.7, 2.9 Hz, 10H), 6.75–6.64 (m, 2H). 13C NMR (101 MHz, chloroform-d) δ 137.30, 130.32, 128.94, 128.28, 127.16.
1,4-Di((Z)-styryl)benzene (2o)28
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 20:1) as a white solid (55 mg, 65%), mp = 85–87°C. 1H NMR (400 MHz, chloroform-d) δ 7.27 (dtd, J = 18.2, 8.0, 3.8 Hz, 10H), 7.15 (t, J = 1.7 Hz, 4H), 6.66–6.52 (m, 4H). 13C NMR (101 MHz, chloroform-d) δ 137.32, 136.05, 130.30, 129.96, 128.86, 128.76, 128.21, 127.14.
(Z)-1,4-Bis(benzyloxy)but-2-ene (2p)29
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 8:1) as a light yellow oil (61 mg, 76%). 1H NMR (400 MHz, chloroform-d) δ 7.35–7.26 (m, 10H), 5.83–5.71 (m, 2H), 4.50–4.43 (m, 4H), 4.05 (t, J = 3.5 Hz, 4H). 13C NMR (101 MHz, chloroform-d) δ 138.19, 129.59, 128.49, 127.87, 127.76, 72.31, 65.82.
1-Methoxy-4-vinylbenzene (2q)30
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 20:1) as a light yellow oil (30 mg, 75%). 1H NMR (400 MHz, chloroform-d) δ 7.48–7.35 (m, 2H), 7.01–6.81 (m, 2H), 6.79–6.65 (m, 1H), 5.66 (dq, J = 17.4, 1.1 Hz, 1H), 5.17 (dt, J = 10.8, 1.3 Hz, 1H), 3.85 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 159.38, 136.24, 130.45, 127.40, 113.92, 111.59, 55.30.
1-Fluoro-4-vinylbenzene (2r)31
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 50:1) as a light yellow oil (26 mg, 71%). 1H NMR (400 MHz, chloroform-d) δ 7.51–7.36 (m, 2H), 7.06 (t, J = 8.7 Hz, 2H), 6.73 (dd, J = 17.6, 10.9 Hz, 1H), 5.71 (d, J = 17.5 Hz, 1H), 5.27 (d, J = 10.9 Hz, 1H). 13C NMR (101 MHz, chloroform-d) δ 162.49 (d, J = 246.8 Hz), 135.71, 133.76 (d, J = 3.4 Hz), 127.76 (d, J = 8.1 Hz), 115.42 (d, J = 21.6 Hz), 113.52 (d, J = 2.3 Hz).
2-Allylisoindoline-1,3-dione (2s)32
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 8:1) as a white solid (47 mg, 84%), mp = 66–68 °C. 1H NMR (400 MHz, chloroform-d) δ 7.87 (dq, J = 6.0, 2.9 Hz, 2H), 7.73 (dt, J = 5.5, 2.7 Hz, 2H), 6.00–5.82 (m, 1H), 5.35–5.15 (m, 2H), 4.31 (dq, J = 5.7, 1.6 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 167.92, 133.98, 132.10, 131.53, 123.31, 117.73, 40.05.
N-Allyl-N-phenylacetamide (2t)33
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 8:1) as a white solid (37.8 mg, 72%), mp = 43–45 °C. 1H NMR (400 MHz, chloroform-d) δ 7.41 (dd, J = 8.3, 6.7 Hz, 2H), 7.38–7.32 (m, 1H), 7.17 (dd, J = 7.5, 1.7 Hz, 2H), 5.88 (ddt, J = 16.6, 10.2, 6.3 Hz, 1H), 5.18–5.02 (m, 2H), 4.31 (dt, J = 6.2, 1.3 Hz, 2H), 1.87 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 170.15, 143.00, 133.14, 129.57, 128.10, 127.87, 117.80, 52.03, 22.72.
3-Allylbenzo[d]oxazol-2(3H)-one (2u)34
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 8:1) as a white solid (41 mg, 78%), mp = 39–40 °C. 1H NMR (400 MHz, chloroform-d) δ 7.27–7.05 (m, 3H), 6.98 (d, J = 7.4 Hz, 1H), 5.91 (ddd, J = 21.4, 10.5, 5.3 Hz, 1H), 5.37–5.23 (m, 2H), 4.46 (dd, J = 5.4, 1.8 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 154.35, 142.64, 130.93, 130.53, 123.80, 122.49, 118.75, 110.00, 108.90, 44.62.
1-Allyl-1,2,3,4-tetrahydroquinoline (2v)35
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 6:1) as a brown oil (47 mg, 92%). 1H NMR (400 MHz, chloroform-d) δ 7.08 (t, J = 7.7 Hz, 1H), 7.00 (dd, J = 7.0, 1.6 Hz, 1H), 6.68–6.54 (m, 2H), 5.90 (dddd, J = 18.2, 10.1, 5.1, 1.1 Hz, 1H), 5.36–5.12 (m, 2H), 3.92 (dq, J = 4.7, 1.5 Hz, 2H), 3.34–3.30 (m, 2H), 2.82 (t, J = 6.3 Hz, 2H), 2.02 (dd, J = 6.6, 5.2 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 145.35, 133.58, 129.01, 127.08, 122.42, 115.91, 115.77, 111.03, 53.87, 49.19, 28.19, 22.35.
But-3-en-1-yl 1-Naphthoate (2w)36
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 10:1) as a light yellow oil (56 mg, 82%). 1H NMR (400 MHz, chloroform-d) δ 8.98 (dd, J = 8.9, 3.6 Hz, 1H), 8.23 (dd, J = 7.3, 1.7 Hz, 1H), 8.04 (d, J = 8.2 Hz, 1H), 7.95–7.88 (m, 1H), 7.65 (tt, J = 8.3, 1.5 Hz, 1H), 7.54 (dt, J = 15.7, 7.4 Hz, 2H), 5.97 (ddtd, J = 17.0, 10.3, 6.7, 1.2 Hz, 1H), 5.35–5.14 (m, 2H), 4.52 (td, J = 6.6, 1.3 Hz, 2H), 2.63 (qd, J = 6.7, 1.3 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 167.56, 134.23, 133.86, 133.33, 131.38, 130.19, 128.56, 127.72, 127.33, 126.21, 125.89, 124.52, 117.47, 64.14, 33.30.
Ethyl Cinnamate (2x)37
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 10:1) as a light yellow oil (47 mg, 90%). 1H NMR (400 MHz, chloroform-d) δ 7.71 (d, J = 16.0 Hz, 1H), 7.54 (dd, J = 6.6, 3.0 Hz, 2H), 7.40 (q, J = 3.0 Hz, 3H), 6.46 (d, J = 16.0 Hz, 1H), 4.29 (q, J = 7.1 Hz, 2H), 1.36 (dd, J = 7.6, 6.7 Hz, 3H). 13C NMR (101 MHz, chloroform-d) δ 166.97, 144.57, 134.48, 130.20, 128.87, 128.04, 118.30, 60.49, 14.33.
Benzyl Cinnamate (2y)38
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 12:1) as a light yellow oil (55 mg, 78%). 1H NMR (400 MHz, chloroform-d) δ 7.75 (dd, J = 16.1, 3.4 Hz, 1H), 7.53 (dd, J = 6.5, 3.1 Hz, 2H), 7.40 (ddt, J = 13.8, 10.5, 5.2 Hz, 8H), 6.51 (dd, J = 16.1, 2.9 Hz, 1H), 5.33–5.21 (m, 2H). 13C NMR (101 MHz, chloroform-d) δ 166.81, 145.21, 136.10, 134.38, 130.38, 128.92, 128.63, 128.31, 128.29, 128.14, 117.91, 66.39.
N-Benzylcinnamamide (2z)39
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 5:1) as a white solid (60 mg, 85%), mp = 108–110 °C. 1H NMR (400 MHz, chloroform-d) δ 7.69 (d, J = 15.6 Hz, 1H), 7.51 (dd, J = 6.7, 2.9 Hz, 2H), 7.45–7.28 (m, 8H), 6.45 (d, J = 15.6 Hz, 1H), 6.10 (s, 1H), 4.59 (d, J = 5.7 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 165.79, 141.41, 138.20, 134.79, 129.72, 128.82, 128.76, 127.93, 127.81, 127.59, 120.45, 43.88.
(Z)-2-(3-(p-Tolyl)allyl-2,3-d2)isoindoline-1,3-dione (d-2g)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 3:1) as a white solid (72 mg, 87%), mp = 85–87 °C. 1H NMR (400 MHz, chloroform-d) δ 7.86 (dd, J = 5.5, 3.1 Hz, 2H), 7.73 (dd, J = 5.5, 3.1 Hz, 2H), 7.30 (d, J = 7.9 Hz, 2H), 7.21 (d, J = 7.8 Hz, 2H), 4.62 (s, 2H), 2.38 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 168.02, 137.10, 133.94, 133.30, 132.17, 129.11, 128.74, 123.26, 36.50, 21.24. HRMS-ESI (m/z): calcd for C18H13D2NO2, [M + H]+: 280.1307, found, 280.1306.
(Z)-3-(3-(p-Tolyl)allyl-2,3-d2)benzo[d]oxazol-2(3H)-one (d-2k)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 3:1) as a white solid (72 mg, 90%), mp = 90–92 °C. 1H NMR (400 MHz, chloroform-d) δ 7.30–7.22 (m, 4H), 7.20 (dd, J = 5.9, 3.3 Hz, 1H), 7.10 (dd, J = 5.8, 3.3 Hz, 2H), 6.73 (dd, J = 5.8, 3.3 Hz, 1H), 4.77 (s, 2H), 2.42 (s, 3H). 13C NMR (101 MHz, chloroform-d) δ 154.31, 142.65, 137.70, 132.83, 130.77, 129.31, 128.77, 123.76, 122.45, 109.92, 108.87, 77.44, 77.12, 76.80, 40.41, 21.28. HRMS-ESI (m/z): calcd for C17H13D2NO2, [M + H]+: 268.1307, found, 268.1309.
(E)-2-(Allyl-2,3-d2)isoindoline-1,3-dione (d-2s)
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 4:1) as a white solid (49 mg, 86%), mp = 62–64 °C. 1H NMR (400 MHz, chloroform-d) δ 7.87 (dd, J = 5.0, 2.5 Hz, 2H), 7.73 (dd, J = 5.5, 2.9 Hz, 2H), 5.24 (s, 0.5H), 4.30 (s, 2H). 13C NMR (101 MHz, chloroform-d) δ 167.93, 133.98, 132.10, 123.31, 39.93. HRMS-ESI (m/z): calcd for C11H16D3NO2, [M + H]+: 191.0900, found, 191.0901.
(Z)-2-(1,2-Diphenylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3)40
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 8:1) as a white solid, (235 mg, 88%), mp = 89–91 °C. 1H NMR (400 MHz, chloroform-d) δ 7.40 (s, 1H), 7.31 (d, J = 8.0 Hz, 2H), 7.26–7.22 (m, 1H), 7.20 (dt, J = 8.1, 1.7 Hz, 2H), 7.17–7.12 (m, 3H), 7.12–7.04 (m, 2H), 1.34 (s, 12H). 13C NMR (101 MHz, chloroform-d) δ 143.17, 140.43, 136.98, 129.96, 128.85, 128.24, 127.85, 127.58, 126.26, 83.79, 77.23, 24.80.
(Z)-N-Benzyl-3-phenylacrylamide ((Z)-2y)41
Purified by flash column chromatography (eluted with petroleum ether/ethyl acetate (v/v) = 5:1) as a white solid, (134 mg, 82%), mp = 110–112 °C. 1H NMR (400 MHz, chloroform-d) δ 7.46–7.39 (m, 2H), 7.33–7.26 (m, 6H), 7.17 (dd, J = 7.5, 2.1 Hz, 2H), 6.80 (d, J = 12.5 Hz, 1H), 6.04 (d, J = 12.5 Hz, 1H), 5.87 (s, 1H), 4.43 (d, J = 5.9 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 166.93, 137.59, 136.51, 134.91, 128.91, 128.64, 128.57, 128.45, 127.99, 127.51, 124.72, 43.60.
Acknowledgments
We are grateful for the financial support from the Fundamental Research Funds for Gannan Medical University (QD202001) for financial support.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.1c01083.
Details of hydrogen-deuterium exchange and control experiments and 1H and 13C NMR spectra of all products (PDF)
The authors declare no competing financial interest.
Supplementary Material
References
- a Fuchs M.; Fürstner A. trans-Hydrogenation: Application to a Concise and Scalable Synthesis of Brefeldin A. Angew. Chem., Int. Ed. 2015, 54, 3978. 10.1002/anie.201411618. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Oger C.; Balas L.; Durand T.; Galano J.-M. Are Alkyne Reductions Chemo-, Regio-, and Stereoselective Enough to Provide Pure (Z)-Olefins in Polyfunctionalized Bioactive Molecules?. Chem. Rev. 2013, 113, 1313. 10.1021/cr3001753. [DOI] [PubMed] [Google Scholar]; c Cirla A.; Mann J. Combretastatins: From Natural Products to Drug Discovery. Nat. Prod. Rep. 2003, 20, 558. 10.1039/b306797c. [DOI] [PubMed] [Google Scholar]; d Fürst R.; Zupkó I.; Berényi Á.; Ecker G. F.; Rinner U. Synthesis and Antitumor-evaluation of Cyclopropyl-Containing Combretastatin Analogs. Bioorg. Med. Chem. Lett. 2009, 19, 6948. 10.1016/j.bmcl.2009.10.064. [DOI] [PubMed] [Google Scholar]
- a Maryanoff B. E.; Reitz A. B. The Wittig Olefination Reaction and Modifications Involving Phosphoryl-stabilized Carbanions. Stereochemistry, Mechanism, and Selected Synthetic Aspects. Chem. Rev. 1989, 89, 863. 10.1021/cr00094a007. [DOI] [Google Scholar]; b Wadsworth W. S.; Emmons W. D. The Utility of Phosphonate Carbanions in Olefin Synthesis. J. Am. Chem. Soc. 1961, 83, 1733. 10.1021/ja01468a042. [DOI] [Google Scholar]; c Peterson D. J. Carbonyl Olefination Reaction Using Silyl-substituted Organometallic Compounds. J. Org. Chem. 1968, 33, 780. 10.1021/jo01266a061. [DOI] [Google Scholar]; d Keitz B. K.; Endo K.; Patel P. R.; Herbert M. B.; Grubbs R. H. Improved Ruthenium Catalysts for Z-Selective Olefin Metathesis. J. Am. Chem. Soc. 2012, 134, 693. 10.1021/ja210225e. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Grubbs R. H.Handbook of Metathesis: Catalyst Development; Wiley-VCH Verlag, 2003. [Google Scholar]; f Trost B. M.; Ball Z. T.; Jöge T. A Chemoselective Reduction of Alkynes to (E)-Alkenes. J. Am. Chem. Soc. 2002, 124, 7922. 10.1021/ja026457l. [DOI] [PubMed] [Google Scholar]; g Wang J.Stereoselective Alkene Synthesis; Springer-Verlag: Berlin, Heidelberg, 2012. [Google Scholar]
- a Gorgas N.; Brünig J.; Stöger B.; Vanicek S.; Tilset M.; Veiros L. F.; Kirchner K. Efficient Z-Selective Semihydrogenation of Internal Alkynes Catalyzed by Cationic Iron(II) Hydride Complexes. J. Am. Chem. Soc. 2019, 141, 17452. 10.1021/jacs.9b09907. [DOI] [PubMed] [Google Scholar]; b Chen C.; Huang Y.; Zhang Z.; Dong X.; Zhang X. Cobalt-catalyzed (Z)-Selective Semihydrogenation of Alkynes with Molecular Hydrogen. Chem. Commun. 2017, 53, 4612. 10.1039/C7CC01228D. [DOI] [PubMed] [Google Scholar]; c Tokmic K.; Fout A. R. Alkyne Semihydrogenation with a Well-Defined Nonclassical Co–H2 Catalyst: A H2 Spin on Isomerization and E-Selectivity. J. Am. Chem. Soc. 2016, 138, 13700. 10.1021/jacs.6b08128. [DOI] [PubMed] [Google Scholar]; d Semba K.; Kameyama R.; Nakao Y. Copper-Catalyzed Semihydrogenation of Alkynes to Z-Alkenes. Synlett 2015, 26, 318. 10.1055/s-0034-1379896. [DOI] [Google Scholar]
- Wang D.; Astruc D. The Golden Age of Transfer Hydrogenation. Chem. Rev. 2015, 115, 6621. 10.1021/acs.chemrev.5b00203. [DOI] [PubMed] [Google Scholar]
- a Fu S.; Chen N.-Y.; Liu X.; Shao Z.; Luo S.-P.; Liu Q. Ligand-Controlled Cobalt-Catalyzed Transfer Hydrogenation of Alkynes: Stereodivergent Synthesis of Z- and E-Alkenes. J. Am. Chem. Soc. 2016, 138, 8588. 10.1021/jacs.6b04271. [DOI] [PubMed] [Google Scholar]; b Korytiaková E.; Thiel N. O.; Pape F.; Teichert J. F. Copper(I)-catalysed Transfer Hydrogenations with Ammonia Borane. Chem. Commun. 2017, 53, 732. 10.1039/C6CC09067B. [DOI] [PubMed] [Google Scholar]
- Wang Y.; Cao X.; Zhao L.; Pi C.; Ji J.; Cui X.; Wu Y. Generalized Chemoselective Transfer Hydrogenation/Hydrodeuteration. Adv. Synth. Catal. 2020, 362, 4119. 10.1002/adsc.202000759. [DOI] [Google Scholar]
- a Belger C.; Neisius N. M.; Plietker B. A Selective Ru-Catalyzed Semireduction of Alkynes to Z Olefins under Transfer-Hydrogenation Conditions. Chem. - Eur. J. 2010, 16, 12214. 10.1002/chem.201001143. [DOI] [PubMed] [Google Scholar]; b Xie R.; Lu G.-P.; Jiang H.-F.; Zhang M. Selective Reductive Annulation Reaction for Direct Synthesis of Functionalized Quinolines by a Cobalt Nanocatalyst. J. Catal. 2020, 383, 239. 10.1016/j.jcat.2020.01.034. [DOI] [Google Scholar]
- a Whittaker A. M.; Lalic G. Monophasic Catalytic System for the Selective Semireduction of Alkynes. Org. Lett. 2013, 15, 1112. 10.1021/ol4001679. [DOI] [PubMed] [Google Scholar]; b Hall J. W.; Unson D. M. L.; Brunel P.; Collins L. R.; Cybulski M. K.; Mahon M. F.; Whittlesey M. K. Copper-NHC-Mediated Semihydrogenation and Hydroboration of Alkynes: Enhanced Catalytic Activity Using Ring-Expanded Carbenes. Organometallics. 2018, 37, 3102. 10.1021/acs.organomet.8b00467. [DOI] [Google Scholar]
- Rao S.; Prabhu K. R. Stereodivergent Alkyne Reduction by using Water as the Hydrogen Source. Chem. - Eur. J. 2018, 24, 13954. 10.1002/chem.201803147. [DOI] [PubMed] [Google Scholar]
- Zhao C.-Q.; Chen Y.-G.; Qiu H.; Wei L.; Fang P.; Mei T.-S. Water as a Hydrogenating Agent: Stereodivergent Pd-Catalyzed Semihydrogenation of Alkynes. Org. Lett. 2019, 21, 1412. 10.1021/acs.orglett.9b00148. [DOI] [PubMed] [Google Scholar]
- Yang J.; Wang C.; Sun Y.; Man X.; Li J.; Sun F. Ligand-controlled Iridium-Catalyzed Semihydrogenation of Alkynes with Ethanol: Highly Stereoselective synthesis of E- and Z-alkenes. Chem. Commun. 2019, 55, 1903. 10.1039/C8CC09714C. [DOI] [PubMed] [Google Scholar]
- a Kaicharla T.; Zimmermann B. M.; Oestreich M.; Teichert J. F. Using Alcohols as Simple H2-equivalents for Copper-Catalysed Transfer Semihydrogenations of Alkynes. Chem. Commun. 2019, 55, 13410. 10.1039/C9CC06637C. [DOI] [PubMed] [Google Scholar]; b Bao H.; Zhou B.; Jin H.; Liu Y. Diboron-Assisted Copper-Catalyzed Z-Selective Semihydrogenation of Alkynes Using Ethanol as a Hydrogen Donor. J. Org. Chem. 2019, 84, 3579. 10.1021/acs.joc.9b00321. [DOI] [PubMed] [Google Scholar]
- a Huang J.; Yan W.; Tan C.; Wu W.; Jiang H. Palladium-Catalyzed Regioselective Hydroboration of Aryl Alkenes with B2pin2. Chem. Commun. 2018, 54, 1770. 10.1039/C7CC09432A. [DOI] [PubMed] [Google Scholar]; b Huang J.; Ouyang L.; Li J.; Zheng J.; Yan W.; Wu W.; Jiang H. B2pin2-Mediated Palladium-Catalyzed Diacetoxylation of Aryl Alkenes with O2 as Oxygen Source and Sole Oxidant. Org. Lett. 2018, 20, 5090. 10.1021/acs.orglett.8b01806. [DOI] [PubMed] [Google Scholar]
- a Hulvey Z.; Melot B. C.; Cheetham A. K. Structure and Magnetic Field-Induced Transition in a One-Dimensional Hybrid Inorganic-Organic Chain System, Co2(4,4′-bpy)(tfhba)2.4,4′-bpy(4,4′-bpy = 4,4′-Bipyridine; tfhba = 2,3,5,6-Tetrafluoro-4-hydroxybenzoate). Inorg. Chem. 2010, 49, 4594. 10.1021/ic100164k. [DOI] [PubMed] [Google Scholar]; b Chen Z.; Xu B.; Li Q.; Meng Y.; Quan Z.; Zou B. Selected Negative Linear Compressibilities in the Metal–Organic Framework of [Cu(4,4′-bpy)2(H2O)2].SiF6. Inorg. Chem. 2020, 59, 1715. 10.1021/acs.inorgchem.9b02884. [DOI] [PubMed] [Google Scholar]
- a Yu S.-H.; Gong T.-J.; Fu Y. Three-Component Borylallenylation of Alkynes: Access to Densely Boryl-Substituted Ene-allenes. Org. Lett. 2020, 22, 2941. 10.1021/acs.orglett.0c00643. [DOI] [PubMed] [Google Scholar]; b Mateos J.; Fuentes-Vara N.; Fra L.; Rivera-Chao E.; Vázquez-Galiñanes N.; Chaves-Pouso A.; Fañanás-Mastral M. Transmetalation as Key Step in the Diastereo- and Enantioselective Synergistic Cu/Pd-Catalyzed Allylboration of Alkynes with Racemic Allylic Carbonates. Organometallics 2020, 39, 740. 10.1021/acs.organomet.0c00010. [DOI] [Google Scholar]; c Zhuo K.-F.; Xu W.-Y.; Gong T.-J.; Fu Y. The Dual-catalyzed Boryldifluoroallylation of Alkynes: an Efficient method for the Synthesis of Skipped gem-Difluorodienes. Chem. Commun. 2020, 56, 2340. 10.1039/C9CC08485A. [DOI] [PubMed] [Google Scholar]
- Tsukamoto H.; Suzuki T.; Kondo Y. Remarkable Solvent Effect on Pd(0)-Catalyzed Deprotection of Allyl Ethers Using Barbituric Acid Derivatives: Application to Selective and Successive Removal of Allyl, Methallyl, and Prenyl Ethers. Synlett 2007, 20, 3131. 10.1055/s-2007-992352. [DOI] [Google Scholar]
- a Ding W.; Song Q. Chemoselective Catalytic Reduction of Conjugated α,β-Unsaturated Ketones to Saturated Ketones via a Hydroboration/protodeboronation Strategy. Org. Chem. Front. 2016, 3, 14. 10.1039/C5QO00289C. [DOI] [Google Scholar]; b Song L.; Ma X.; Xu S.; Shi M.; Zhang J. Regiospecific and stereoselective synthesis of (E)- and (Z)-2-phosphino-1-alkenyl boronates via Cu-catalyzed hydroboration of alkynylphosphines. New J. Chem. 2018, 42, 8342. 10.1039/C8NJ00892B. [DOI] [Google Scholar]; c Jiang G.; Wang S.; Zhang J.; Yu J.; Zhang Z.; Ji F. Palladium-Catalyzed Primary Amine-Directed Decarboxylative Annulation of α-Oxocarboxylic Acids: Access to Indolo[1,2-a]quinazolines. Adv. Synth. Catal. 2019, 361, 1798. 10.1002/adsc.201900001. [DOI] [Google Scholar]; d Liu X.; Ming W.; Friedrich A.; Kerner F.; Marder T. B. Copper-Catalyzed Triboration of Terminal Alkynes Using B2pin2: Efficient Synthesis of 1,1,2-Triborylalkenes. Angew. Chem., Int. Ed. 2020, 59, 304. 10.1002/anie.201908466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- a de Oliveira I. M.; Esteves H. A.; Darbem M. P.; Sartorelli A.; Correra T. C.; Rodrigues-Oliveira A. F.; Pimenta D. C.; Zukerman-Schpector J.; Manarin F.; Stefani H. A. Stereo- and Regioselective Cu-Catalyzed Hydroboration of Alkynyl Chalcogenoethers. ChemCatChem 2020, 12, 3545. 10.1002/cctc.202000395. [DOI] [Google Scholar]; b Yoshida H.; Takemotoa Y.; Takaki K. A Masked Diboron in Cu-catalysed Borylation Reaction: Highly Regioselective Formal Hydroboration of Alkynes for Synthesis of Branched Alkenylborons. Chem. Commun. 2014, 50, 8299. 10.1039/C4CC01757A. [DOI] [PubMed] [Google Scholar]
- a Nagao K.; Ohmiya H.; Sawamura M. Anti-Selective Vicinal Silaboration and Diboration of Alkynoates through Phosphine Organocatalysis. Org. Lett. 2015, 17, 1304. 10.1021/acs.orglett.5b00305. [DOI] [PubMed] [Google Scholar]; b Verma A.; Snead R. F.; Dai Y.; Slebodnick C.; Yang Y.; Yu H.; Yao F.; Santos W. L. Substrate-Assisted, Transition-Metal-Free Diboration of Alkynamides with Mixed Diboron: Regio- and Stereoselective Access to trans-1,2-Vinyldiboronates. Angew. Chem., Int. Ed. 2017, 56, 5111. 10.1002/anie.201700946. [DOI] [PubMed] [Google Scholar]
- Ishida T.; Kobayashi R.; Yamada T. Novel Method of Tetramic Acid Synthesis: Silver-Catalyzed Carbon Dioxide Incorporation into Propargylic Amine and Intramolecular Rearrangement. Org. Lett. 2014, 16, 2430. 10.1021/ol500806u. [DOI] [PubMed] [Google Scholar]
- Xie J.; Guo Z.; Huang Y.; Qu Y.; Song H.; Song H.; Liu Y.; Wang Q. One-Pot Copper-Catalyzed Cascade Bicyclization Strategy for Synthesis of 2-(1H-Indol-1-yl)-4,5-dihydrothiazoles and 2-(1H-Indol-1-yl)thiazol-5-yl Aryl Ketones with Molecular Oxygen as an Oxygen Source. Adv. Synth. Catal. 2019, 361, 490. 10.1002/adsc.201801193. [DOI] [Google Scholar]
- Denton T. T.; Zhang X.; Cashman J. R. 5-Substituted, 6-Substituted, and Unsubstituted 3-Heteroaromatic Pyridine Analogues of Nicotine as Selective Inhibitors of Cytochrome P-450 2A6. J. Med. Chem. 2005, 48, 224. 10.1021/jm049696n. [DOI] [PubMed] [Google Scholar]
- Ketcham J. M.; Biannica B.; Aponick A. The tandem intermolecular hydroalkoxylation/claisen rearrangement. Chem. Commun. 2013, 49, 4157. 10.1039/C2CC37166A. [DOI] [PubMed] [Google Scholar]
- Arhtur B. T.; James C. R.; Kelvin L.; Mei L.; Ian M. A.; Duane T. D.. Pytido[2,3-D]Pyrimidine-2,4-Diamines As PDE 2 Inhibitors. WO Patent WO2005614972005.
- Guo J.; Wang Y.; Li Y.; Lu K.; Liu S.; Wang W.; Zhang Y. Graphitic Carbon Nitride Polymer as a Recyclable Photoredox Catalyst for Decarboxylative Alkynylation of Carboxylic Acids. Adv. Synth. Catal. 2020, 362, 3898. 10.1002/adsc.202000777. [DOI] [Google Scholar]
- Chen C.; Huang Y.; Zhang Z.; Dong X.-Q.; Zhang X. Cobalt-catalyzed (Z)-selective semihydrogenation of alkynes with molecular hydrogen. Chem. Commun. 2017, 53, 4612. 10.1039/C7CC01228D. [DOI] [PubMed] [Google Scholar]
- Zubar V.; Sklyaruk J.; Brzozowska A.; Rueping M. Chemoselective Hydrogenation of Alkynes to (Z)-Alkenes Using an Air-Stable Base Metal Catalyst. Org. Lett. 2020, 22, 5423. 10.1021/acs.orglett.0c01783. [DOI] [PubMed] [Google Scholar]
- Sklyaruk J.; Zubar V.; Borghs J. C.; Rueping M. Methanol as the Hydrogen Source in the Selective Transfer Hydrogenation of Alkynes Enabled by a Manganese Pincer Complex. Org. Lett. 2020, 22, 6067. 10.1021/acs.orglett.0c02151. [DOI] [PubMed] [Google Scholar]
- Borrel J.; Pisella G.; Waser J. Copper-Catalyzed Oxyalkynylation of C–S Bonds in Thiiranes and Thiethanes with Hypervalent Iodine Reagents. Org. Lett. 2020, 22, 422–427. 10.1021/acs.orglett.9b04157. [DOI] [PubMed] [Google Scholar]
- Perkowski A. J.; You W.; Nicewicz D. A. Visible Light Photoinitiated Metal-Free Living Cationic Polymerization of 4-Methoxystyrene. J. Am. Chem. Soc. 2015, 137, 7580. 10.1021/jacs.5b03733. [DOI] [PubMed] [Google Scholar]
- Friedle S.; Thomas S. W. III Controlling Contact Electrification with Photochromic Polymers. Angew. Chem., Int. Ed. 2010, 49, 7968. 10.1002/anie.201003985. [DOI] [PubMed] [Google Scholar]
- Meng N.; Wang L.; Liu Q.; Li Q.; Lv Y.; Yue H.; Wang X.; Wei W. Metal-Free Trifluoroalkylation of Quinoxalin-2(1H)-ones with Unactivated Alkenes and Langlois’ Reagent. J. Org. Chem. 2020, 85, 6888. 10.1021/acs.joc.9b03505. [DOI] [PubMed] [Google Scholar]
- Huang W.; Li X.; Song X.; Luo Q.; Li Y.; Dong Y.; Liang D.; Wang B. Benzylarylation of N-Allyl Anilines: Synthesis of Benzylated Indolines. J. Org. Chem. 2019, 84, 6072. 10.1021/acs.joc.9b00237. [DOI] [PubMed] [Google Scholar]
- Ram R. N.; Soni V. K. Synthesis of 3-Alkylbenzoxazolones from N-Alkyl-N-arylhydroxylamines by Contiguous O-Trichloroacetylation, Trichloroacetoxy ortho-Shift, and Cyclization Sequence. J. Org. Chem. 2013, 78, 11935. 10.1021/jo401985h. [DOI] [PubMed] [Google Scholar]
- Jing J.; Huo X.; Shen J.; Fu J.; Meng Q.; Zhang W. Direct use of allylic alcohols and allylic amines in palladium-catalyzed allylic amination. Chem. Commun. 2017, 53, 5151. 10.1039/C7CC01069A. [DOI] [PubMed] [Google Scholar]
- Lipshutz B. H.; Ghorai S.; Leong W. W. Y. Deprotection of Homoallyl (hAllyl) Derivatives of Phenols, Alcohols, Acids, and Amines. J. Org. Chem. 2009, 74, 2854. 10.1021/jo900012z. [DOI] [PubMed] [Google Scholar]
- Zhang B.; Feng P.; Cui Y.; Jiao N. NHC-catalyzed C–O or C–N bond formation: efficient approaches to α,β-unsaturated esters and amides. Chem. Commun. 2012, 48, 7280. 10.1039/c2cc32862c. [DOI] [PubMed] [Google Scholar]
- Mahajani N. S.; Meador R. I. L.; Smith T. J.; Canarelli S. E.; Adhikari A. A.; Shah J. P.; Russo C. M.; Wallach D. R.; Howard K. T.; Millimaci A. M.; Chisholm J. D. Ester Formation via Symbiotic Activation Utilizing Trichloroacetimidate Electrophiles. J. Org. Chem. 2019, 84, 7871. 10.1021/acs.joc.9b00745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gao T.-T.; Zhang W.-W.; Sun X.; Lu H.-X.; Li B.-J. Stereodivergent Synthesis through Catalytic Asymmetric Reversed Hydroboration. J. Am. Chem. Soc. 2019, 141, 4670. 10.1021/jacs.8b13520. [DOI] [PubMed] [Google Scholar]
- Whyte A.; Torelli A.; Mirabi B.; Prieto L.; Rodríguez J. F.; Lautens M. Cobalt-Catalyzed Enantioselective Hydroarylation of 1,6-Enynes. J. Am. Chem. Soc. 2020, 142, 9510. 10.1021/jacs.0c03246. [DOI] [PubMed] [Google Scholar]
- Lee H.; Cho S.; Lee Y.; Jung B. Stereoselective Formal Hydroamidation of Si-Substituted Arylacetylenes with DIBAL-H and Isocyanates: Synthesis of (E)- and (Z)-α-Silyl-α,β-unsaturated Amides. J. Org. Chem. 2020, 85, 12024. 10.1021/acs.joc.0c01903. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.